<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Saudi J Anaesth</journal-id><journal-id journal-id-type="publisher-id">SJA</journal-id><journal-title-group><journal-title>Saudi Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">1658-354X</issn><issn pub-type="epub">0975-3125</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24015121</article-id><article-id pub-id-type="pmc">3757791</article-id><article-id pub-id-type="publisher-id">SJA-7-229</article-id><article-id pub-id-type="doi">10.4103/1658-354X.115314</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of tranexamic acid during endoscopic sinsus surgery in children</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eldaba</surname><given-names>Ahmed A.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Amr</surname><given-names>Yasser Mohamed</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Albirmawy</surname><given-names>Osama A.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1"><italic>Department of Anesthesia and Surgical Intensive Care, Tanta University, Tanta, Egypt</italic></aff><aff id="aff2"><label>1</label><italic>Department of ENT, Tanta University Hospital, Tanta University, Tanta, Egypt</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Yasser Mohamed Amr, Department of Anesthesia, Tanta University Hospital, Tanta University, Tanta 31257, Egypt. E-mail: <email xlink:href="yasser.amr@gmail.com">yasser.amr@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2013</year></pub-date><volume>7</volume><issue>3</issue><fpage>229</fpage><lpage>233</lpage><permissions><copyright-statement>Copyright: © Saudi Journal of Anaesthesia</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2969" xml_f="2980" txt_i="11" txt_f="22">Objectives:</offsets></title><p><offsets xml_i="2991" xml_f="3161" txt_i="23" txt_f="193">This study was conducted to evaluate the effect of tranexamic acid (TA) on the intra-operative bleeding during the functional endoscopic sinus surgery (FESS) in children.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3192" xml_f="3200" txt_i="195" txt_f="203">Methods:</offsets></title><p><offsets xml_i="3211" xml_f="3615" txt_i="204" txt_f="608">A total of 100 children recruited to undergo FESS were randomized into two groups. Group I: Was given just after induction, intra-venous 25 mg/kg TA diluted in 10 ml of normal saline. Group II: Was given 10 ml of normal saline. Non-invasive blood pressure, heart rate, and quality of the surgical field were estimated every 15 min. Volume of bleeding and duration of the surgical procedure were recorded.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3646" xml_f="3654" txt_i="610" txt_f="618">Results:</offsets></title><p><offsets xml_i="3665" xml_f="3789" txt_i="619" txt_f="743">Surgical field quality after 15 min revealed that seven patients in group I had minimal bleeding versus no one in group II, </offsets><italic><offsets xml_i="3797" xml_f="3798" txt_i="743" txt_f="744">P</offsets></italic><offsets xml_i="3807" xml_f="3899" txt_i="744" txt_f="836">=0.006. Meanwhile, 35 patients in group I had mild bleeding versus 26 patients in group II, </offsets><italic><offsets xml_i="3907" xml_f="3908" txt_i="836" txt_f="837">P</offsets></italic><offsets xml_i="3917" xml_f="4002" txt_i="837" txt_f="922">=0.064. Higher number of patients in group II than in group I had moderate bleeding, </offsets><italic><offsets xml_i="4010" xml_f="4011" txt_i="922" txt_f="923">P</offsets></italic><offsets xml_i="4020" xml_f="4134" txt_i="923" txt_f="1037">=0006. Also, at 30 min, revealed that 10 patients in group I had minimal bleeding versus one patient in group II, </offsets><italic><offsets xml_i="4142" xml_f="4143" txt_i="1037" txt_f="1038">P</offsets></italic><offsets xml_i="4152" xml_f="4244" txt_i="1038" txt_f="1130">=0.004. Meanwhile, 37 patients in group I had mild bleeding versus 28 patients in group II, </offsets><italic><offsets xml_i="4252" xml_f="4253" txt_i="1130" txt_f="1131">P</offsets></italic><offsets xml_i="4262" xml_f="4347" txt_i="1131" txt_f="1216">=0.059. Higher number of patients in group II than in group I had moderate bleeding, </offsets><italic><offsets xml_i="4355" xml_f="4356" txt_i="1216" txt_f="1217">P</offsets></italic><offsets xml_i="4365" xml_f="4492" txt_i="1217" txt_f="1341">&lt;0001. Duration of the surgeries and volume of bleeding were significantly less in tranexamic group than the placebo group, </offsets><italic><offsets xml_i="4500" xml_f="4501" txt_i="1341" txt_f="1342">P</offsets></italic><offsets xml_i="4510" xml_f="4521" txt_i="1342" txt_f="1350">&lt;0.0001.</offsets></p></sec><sec id="st4"><title><offsets xml_i="4552" xml_f="4563" txt_i="1352" txt_f="1363">Conclusion:</offsets></title><p><offsets xml_i="4574" xml_f="4741" txt_i="1364" txt_f="1531">Single intra-venous bolus dose of tranexamic in children during the FESS improves quality of surgical field, reduces intra-operative bleeding, and duration of surgery.</offsets></p></sec></abstract><kwd-group><kwd><italic>Children</italic></kwd><kwd><italic>functional endoscopic sinus surgery</italic></kwd><kwd><italic>tranexamic acid</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="4980" xml_f="4992" txt_i="1540" txt_f="1552">INTRODUCTION</offsets></title><p><offsets xml_i="5003" xml_f="5131" txt_i="1553" txt_f="1681">Treatment of chronic sinusitis using the functional endoscopic sinus surgery (FESS) has become popular among otolaryngologists.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="5164" xml_f="5165" txt_i="1681" txt_f="1682">1</offsets></xref><offsets xml_i="5172" xml_f="5173" txt_i="1682" txt_f="1683">]</offsets></p><p><offsets xml_i="5180" xml_f="5237" txt_i="1684" txt_f="1741">The procedure became an accepted treatment for children.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="5270" xml_f="5271" txt_i="1741" txt_f="1742">2</offsets></xref><offsets xml_i="5278" xml_f="5441" txt_i="1742" txt_f="1905">] It must be carried out under general anesthesia. Several published series of children undergoing FESS have described positive outcomes ranging from 80% to 100%.[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="5474" xml_f="5475" txt_i="1905" txt_f="1906">3</offsets></xref><xref ref-type="bibr" rid="ref4"><offsets xml_i="5515" xml_f="5516" txt_i="1906" txt_f="1907">4</offsets></xref><offsets xml_i="5523" xml_f="5651" txt_i="1907" txt_f="2035">] The most common complication during the FESS is bleeding, which sometimes prevents the surgeon from completing the procedure.[</offsets><xref ref-type="bibr" rid="ref5"><offsets xml_i="5684" xml_f="5685" txt_i="2035" txt_f="2036">5</offsets></xref><xref ref-type="bibr" rid="ref6"><offsets xml_i="5725" xml_f="5726" txt_i="2036" txt_f="2037">6</offsets></xref><xref ref-type="bibr" rid="ref7"><offsets xml_i="5766" xml_f="5767" txt_i="2037" txt_f="2038">7</offsets></xref><offsets xml_i="5774" xml_f="5775" txt_i="2038" txt_f="2039">]</offsets></p><p><offsets xml_i="5782" xml_f="6261" txt_i="2040" txt_f="2519">Tranexamic acid (TA) is a synthetic derivative of the amino acid lysine that exerts its antifibrinolytic effect through the reversible blockade of lysine binding sites on plasminogen molecules and thereby inhibiting the interaction of plasminogen and the heavy chain of plasmin with lysine residues on the surface of fibrin. Suppression of fibrinolysis by TA is manifested by reduction in blood levels of D-Dimer. However, the drug has no effect on blood coagulation parameters.[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="6294" xml_f="6295" txt_i="2519" txt_f="2520">8</offsets></xref><xref ref-type="bibr" rid="ref9"><offsets xml_i="6335" xml_f="6336" txt_i="2520" txt_f="2521">9</offsets></xref><offsets xml_i="6343" xml_f="6344" txt_i="2521" txt_f="2522">]</offsets></p><p><offsets xml_i="6351" xml_f="6461" txt_i="2523" txt_f="2633">This study was conducted to evaluate the effect of TA on the intra-operative bleeding during FESS in children.</offsets></p></sec><sec sec-type="methods" id="sec1-2"><title><offsets xml_i="6514" xml_f="6521" txt_i="2635" txt_f="2642">METHODS</offsets></title><p><offsets xml_i="6532" xml_f="6857" txt_i="2643" txt_f="2968">A total of 100 children suffering from the chronic rhinosinusitis and aged between 5 years and 10 years were recruited to undergo FESS, these patients’ first time candidates for sinus surgery. The protocol of the study was approved by the institutional ethical committee. A written informed consent was signed by the parents.</offsets></p><p><offsets xml_i="6864" xml_f="7309" txt_i="2969" txt_f="3414">Exclusion criteria included refusal of the parents, systemic diseases affecting the nose, medical treatment affecting the study or any congenital anomalies, patients with pre-existing renal and hepatic disorders, bleeding diathesis and abnormal prothrombin time, partial thromboplastin time (PTT) or platelet counts were excluded from the study. Usage of non-steroidal anti-inflammatory drugs within 7 days of surgery was an exclusion criterion.</offsets></p><p><offsets xml_i="7316" xml_f="7668" txt_i="3415" txt_f="3767">General anesthesia was used for all patients. However, before arrival to the operating theater, topical decongestant spray (Afrin) was applied. Oral midazolam (0.5 mg/kg, 30 min before induction) was utilized to reduce the pediatric pre-operative anxiety. Children were pre-medicated with fentanyl intra-venously 1 μg/kg before induction of anesthesia.</offsets></p><p><offsets xml_i="7675" xml_f="8040" txt_i="3768" txt_f="4133">Face mask of the correct size was held close to the patient's face with 1% sevoflurane in oxygen 3 l/min. Increase in concentration of sevoflurane (1%) was carried out after every three breaths of patient. Concentration of sevoflurane was increased until the child was breathing 8% sevoflurane. Then, intubation was facilitated by intra-venous atracurium 0.5 mg/Kg.</offsets></p><p><offsets xml_i="8047" xml_f="8450" txt_i="4134" txt_f="4537">Anesthesia was maintained with 2.5% sevoflurane in 100% oxygen with total flow of 3 l/min. Mechanical ventilation was at a tidal volume of 8 ml/kg, and respiratory rate was adjusted by age to give an end-tidal carbon dioxide tension of 35-40 mmHg. Lactated Ringer's solution was administered at 8 ml/kg/h. While, the inspiratory and end-tidal sevoflurane concentration had been maintained at 2.0 Vol. %.</offsets></p><p><offsets xml_i="8457" xml_f="8585" txt_i="4538" txt_f="4666">After induction of anesthesia, the surgical site was infiltrated with 1:200.000 epinephrine for topical vasoconstriction (1 ml).</offsets></p><p><offsets xml_i="8592" xml_f="8670" txt_i="4667" txt_f="4745">Then, children were classified randomize into two groups, 50 patients in each.</offsets></p><p><offsets xml_i="8677" xml_f="8894" txt_i="4746" txt_f="4963">Randomization was performed using a computer based random number generator in permutated blocks of varying sizes and the assignment entered in sealed envelopes that were not opened until informed consent was obtained.</offsets></p><p><list list-type="bullet"><list-item><p><offsets xml_i="8940" xml_f="9075" txt_i="4964" txt_f="5099">Group I: Was given after induction, intra-venous 25 mg/Kg TA diluted in 10 ml of normal saline (slow intra-venous injection in 3-5 min)</offsets></p></list-item><list-item><p><offsets xml_i="9105" xml_f="9183" txt_i="5100" txt_f="5178">Group II: Was given 10 ml of normal saline (slow intra-venous within 3-5 min).</offsets></p></list-item></list></p><p><offsets xml_i="9213" xml_f="9464" txt_i="5180" txt_f="5431">Anesthesiologists, operating personnel, and study staff were blind as to treatment groups; the same anesthesia team performed all procedures. A blinded chief nurse who did not participate in the study protocol or data collection prepared the syringes.</offsets></p></sec><sec id="sec1-3"><title><offsets xml_i="9498" xml_f="9510" txt_i="5433" txt_f="5445">MEASUREMENTS</offsets></title><p><offsets xml_i="9521" xml_f="9759" txt_i="5446" txt_f="5684">During maintenance of anesthesia, non-invasive blood pressure, and heart rate were recorded before induction of anesthesia as a base line, after induction of anesthesia, every 15 min during the surgery and then immediately after recovery.</offsets></p><p><offsets xml_i="9766" xml_f="9919" txt_i="5685" txt_f="5838">The surgeon estimated the quality of the surgical field every 15 min during the surgical procedure with a predefined scale adapted from that of Boezaart </offsets><italic><offsets xml_i="9927" xml_f="9932" txt_i="5838" txt_f="5843">et al</offsets></italic><offsets xml_i="9941" xml_f="9943" txt_i="5843" txt_f="5845">.[</offsets><xref ref-type="bibr" rid="ref10"><offsets xml_i="9977" xml_f="9979" txt_i="5845" txt_f="5847">10</offsets></xref><offsets xml_i="9986" xml_f="9987" txt_i="5847" txt_f="5848">]</offsets></p><p><offsets xml_i="9994" xml_f="10009" txt_i="5849" txt_f="5864">0 = No bleeding</offsets></p><p><offsets xml_i="10016" xml_f="10085" txt_i="5865" txt_f="5934">1 = Minimal bleeding: Not a surgical nuisance and no suction required</offsets></p><p><offsets xml_i="10092" xml_f="10170" txt_i="5935" txt_f="6013">2 = Mild bleeding: Occasional suction required, but does not affect dissection</offsets></p><p><offsets xml_i="10177" xml_f="10262" txt_i="6014" txt_f="6099">3 = Moderate bleeding: Slightly compromises surgical field, frequent suction required</offsets></p><p><offsets xml_i="10269" xml_f="10410" txt_i="6100" txt_f="6241">4 = Severe bleeding: Significantly compromises surgical field, frequent suction required, bleeding threat field just after removal of suction</offsets></p><p><offsets xml_i="10417" xml_f="10458" txt_i="6242" txt_f="6283">5 = Massive bleeding: Prevent dissection.</offsets></p><p><offsets xml_i="10465" xml_f="10706" txt_i="6284" txt_f="6525">All procedures were performed by the same surgical team using the same technique. Cutting forceps and grabbing instruments were used, but a microdebrider was not used in the present study. The surgical team was blinded to the study protocol.</offsets></p><p><offsets xml_i="10713" xml_f="10801" txt_i="6526" txt_f="6614">The blood loss was estimated by weighing sponges and measuring operative suction volume.</offsets></p><p><offsets xml_i="10808" xml_f="10875" txt_i="6615" txt_f="6682">Time of operation (from induction to extubation) would be recorded.</offsets></p><p><offsets xml_i="10882" xml_f="10970" txt_i="6683" txt_f="6771">Muscle relaxation was antagonized at the end of the surgery by neostagmine and atropine.</offsets></p><p><offsets xml_i="10977" xml_f="11141" txt_i="6772" txt_f="6936">Side-effects of TA such as nausea, vomiting, pruritus, hematoma or hemorrhage, thrombotic complications, local infection, fever or convulsive seizure were reported.</offsets></p><sec id="sec2-1"><title><offsets xml_i="11169" xml_f="11189" txt_i="6937" txt_f="6957">Statistical analysis</offsets></title><p><offsets xml_i="11200" xml_f="11580" txt_i="6958" txt_f="7338">Sample size calculation was conducted using the surgical area bleeding score as the main response variable. Power analysis identified 35 patients per group, required to detect 15% difference between groups with a power 80% and a significant level of 0.05. However, to enable detection of potential variations and avoid potential errors, fifty patients were included in each group.</offsets></p><p><offsets xml_i="11587" xml_f="11726" txt_i="7339" txt_f="7478">Comparison of demographic data, amount of the blood loss and duration of the surgeries between the groups was carried out by the Student's </offsets><italic><offsets xml_i="11734" xml_f="11735" txt_i="7478" txt_f="7479">t</offsets></italic><offsets xml_i="11744" xml_f="11920" txt_i="7479" txt_f="7655">-test. Two-way analysis of variance with correction for repeated measurements was used for heart rate and blood pressure comparison. Chi-square test was used when appropriate. </offsets><italic><offsets xml_i="11928" xml_f="11929" txt_i="7655" txt_f="7656">P</offsets></italic><offsets xml_i="11938" xml_f="11974" txt_i="7656" txt_f="7689">&lt;0.05 was considered significant.</offsets></p></sec></sec><sec sec-type="results" id="sec1-4"><title><offsets xml_i="12033" xml_f="12040" txt_i="7692" txt_f="7699">RESULTS</offsets></title><p><offsets xml_i="12051" xml_f="12199" txt_i="7700" txt_f="7848">A total of 100 patients scheduled for FESS were enrolled in the study. Demographic data, duration of surgeries and volume of bleeding are shown in [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="12231" xml_f="12238" txt_i="7848" txt_f="7855">Table 1</offsets></xref><offsets xml_i="12245" xml_f="12461" txt_i="7855" txt_f="8071">]. There was no significant difference between groups as regards to age, gender and weight. Meanwhile, duration of surgeries and volume of bleeding were significantly less in tranexamic group than the placebo group, </offsets><italic><offsets xml_i="12469" xml_f="12470" txt_i="8071" txt_f="8072">P</offsets></italic><offsets xml_i="12479" xml_f="12490" txt_i="8072" txt_f="8080">&lt;0.0001.</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="12538" xml_f="12545" txt_i="8081" txt_f="8088">Table 1</offsets></label><caption><p><offsets xml_i="12565" xml_f="12627" txt_i="8088" txt_f="8150">Demographic data, duration of surgeries and volume of bleeding</offsets></p></caption><graphic xlink:href="SJA-7-229-g001"></graphic></table-wrap><sec id="sec2-2"><title><offsets xml_i="12725" xml_f="12744" txt_i="8151" txt_f="8170">Hemodynamic changes</offsets></title><p><offsets xml_i="12755" xml_f="12830" txt_i="8171" txt_f="8246">Heart rate and mean arterial blood pressure were comparable in both groups </offsets><italic><offsets xml_i="12838" xml_f="12839" txt_i="8246" txt_f="8247">P</offsets></italic><offsets xml_i="12848" xml_f="12866" txt_i="8247" txt_f="8262">&gt;0.05, [Tables </offsets><xref ref-type="table" rid="T2"><offsets xml_i="12898" xml_f="12899" txt_i="8262" txt_f="8263">2</offsets></xref><offsets xml_i="12906" xml_f="12911" txt_i="8263" txt_f="8268"> and </offsets><xref ref-type="table" rid="T3"><offsets xml_i="12943" xml_f="12944" txt_i="8268" txt_f="8269">3</offsets></xref><offsets xml_i="12951" xml_f="12953" txt_i="8269" txt_f="8271">].</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="13001" xml_f="13008" txt_i="8272" txt_f="8279">Table 2</offsets></label><caption><p><offsets xml_i="13028" xml_f="13079" txt_i="8279" txt_f="8330">Mean arterial blood pressure changes in both groups</offsets></p></caption><graphic xlink:href="SJA-7-229-g002"></graphic></table-wrap><table-wrap id="T3" position="float"><label><offsets xml_i="13197" xml_f="13204" txt_i="8331" txt_f="8338">Table 3</offsets></label><caption><p><offsets xml_i="13224" xml_f="13257" txt_i="8338" txt_f="8371">Heart rate changes in both groups</offsets></p></caption><graphic xlink:href="SJA-7-229-g003"></graphic></table-wrap></sec><sec id="sec2-3"><title><offsets xml_i="13361" xml_f="13390" txt_i="8373" txt_f="8402">Quality of the surgical field</offsets></title><p><offsets xml_i="13401" xml_f="13473" txt_i="8403" txt_f="8475">Grading of the surgical field quality at 15 min of surgical procedure, [</offsets><xref ref-type="table" rid="T4"><offsets xml_i="13505" xml_f="13512" txt_i="8475" txt_f="8482">Table 4</offsets></xref><offsets xml_i="13519" xml_f="13664" txt_i="8482" txt_f="8627">] revealed that 7 patients in group I had minimal bleeding, which was not a surgical nuisance and no suction required versus no one in group II, </offsets><italic><offsets xml_i="13672" xml_f="13673" txt_i="8627" txt_f="8628">P</offsets></italic><offsets xml_i="13682" xml_f="13839" txt_i="8628" txt_f="8785">=0.006. Meanwhile, 35 patients in group I had mild bleeding with occasional suction required, but does not affect dissection versus 26 patients in group II, </offsets><italic><offsets xml_i="13847" xml_f="13848" txt_i="8785" txt_f="8786">P</offsets></italic><offsets xml_i="13857" xml_f="14009" txt_i="8786" txt_f="8938">=0.064. Higher number of patients in group II than in group I had moderate bleeding slightly compromises surgical field, and frequent suction required, </offsets><italic><offsets xml_i="14017" xml_f="14018" txt_i="8938" txt_f="8939">P</offsets></italic><offsets xml_i="14027" xml_f="14033" txt_i="8939" txt_f="8945">=0006.</offsets></p><table-wrap id="T4" position="float"><label><offsets xml_i="14081" xml_f="14088" txt_i="8946" txt_f="8953">Table 4</offsets></label><caption><p><offsets xml_i="14108" xml_f="14213" txt_i="8953" txt_f="9058">Quality of field 15 min after starting surgical procedure (data were expressed as the number of patients)</offsets></p></caption><graphic xlink:href="SJA-7-229-g004"></graphic></table-wrap><p><offsets xml_i="14290" xml_f="14361" txt_i="9059" txt_f="9130">Grading of the surgical field quality at 30 min of surgical procedure [</offsets><xref ref-type="table" rid="T5"><offsets xml_i="14393" xml_f="14400" txt_i="9130" txt_f="9137">Table 5</offsets></xref><offsets xml_i="14407" xml_f="14559" txt_i="9137" txt_f="9289">], revealed that 10 patients in group I had minimal bleeding, which was not a surgical nuisance and no suction required versus one patient in group II, </offsets><italic><offsets xml_i="14567" xml_f="14568" txt_i="9289" txt_f="9290">P</offsets></italic><offsets xml_i="14577" xml_f="14734" txt_i="9290" txt_f="9447">=0.004. Meanwhile, 37 patients in group I had mild bleeding with occasional suction required, but does not affect dissection versus 28 patients in group II, </offsets><italic><offsets xml_i="14742" xml_f="14743" txt_i="9447" txt_f="9448">P</offsets></italic><offsets xml_i="14752" xml_f="14900" txt_i="9448" txt_f="9596">=0.059. Higher number of patients in group II than in group I had moderate bleeding slightly compromises surgical field, frequent suction required, </offsets><italic><offsets xml_i="14908" xml_f="14909" txt_i="9596" txt_f="9597">P</offsets></italic><offsets xml_i="14918" xml_f="14929" txt_i="9597" txt_f="9605">&lt;0.0001.</offsets></p><table-wrap id="T5" position="float"><label><offsets xml_i="14977" xml_f="14984" txt_i="9606" txt_f="9613">Table 5</offsets></label><caption><p><offsets xml_i="15004" xml_f="15109" txt_i="9613" txt_f="9718">Quality of field 30 min after starting surgical procedure (data were expressed as the number of patients)</offsets></p></caption><graphic xlink:href="SJA-7-229-g005"></graphic></table-wrap></sec></sec><sec sec-type="discussion" id="sec1-5"><title><offsets xml_i="15241" xml_f="15251" txt_i="9721" txt_f="9731">DISCUSSION</offsets></title><p><offsets xml_i="15262" xml_f="15463" txt_i="9732" txt_f="9933">The development of pediatric endoscopy of the nose and sinuses, as well as diagnostic radiological tests has contributed naturally, to a quicker and more adequate diagnosis of chronic rhino sinusitis.[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="15496" xml_f="15497" txt_i="9933" txt_f="9934">4</offsets></xref><offsets xml_i="15504" xml_f="15597" txt_i="9934" txt_f="10027">] Various methods are used to reduce the bleeding to guarantee better visibility during FESS.</offsets></p><p><offsets xml_i="15604" xml_f="15752" txt_i="10028" txt_f="10176">Pre-operative steroid administration in cases of severe nasal polyposis improves visibility due to its anti-inflammatory and anti-edematous effect.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="15786" xml_f="15788" txt_i="10176" txt_f="10178">11</offsets></xref><offsets xml_i="15795" xml_f="15925" txt_i="10178" txt_f="10308">] Topical vasoconstrictors are applied to decrease blood loss and mucosal congestion, but hypertension and tachycardia may occur,[</offsets><xref ref-type="bibr" rid="ref12"><offsets xml_i="15959" xml_f="15961" txt_i="10308" txt_f="10310">12</offsets></xref><offsets xml_i="15968" xml_f="16049" txt_i="10310" txt_f="10391">] controlled hypotension is commonly used to achieve blood less operative field.[</offsets><xref ref-type="bibr" rid="ref13"><offsets xml_i="16083" xml_f="16085" txt_i="10391" txt_f="10393">13</offsets></xref><offsets xml_i="16092" xml_f="16093" txt_i="10393" txt_f="10394">]</offsets></p><p><offsets xml_i="16100" xml_f="16374" txt_i="10395" txt_f="10669">Studies have looked the effect of TA as an antifibrinolytic agent in reducing bleeding during and after nasal surgery, through intra-venous, oral and nasal routes and reveled the reduction of intra-operative bleeding and improvement of the surgical field in adult patients.[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="16408" xml_f="16410" txt_i="10669" txt_f="10671">14</offsets></xref><xref ref-type="bibr" rid="ref15"><offsets xml_i="16451" xml_f="16453" txt_i="10671" txt_f="10673">15</offsets></xref><offsets xml_i="16460" xml_f="16549" txt_i="10673" txt_f="10762">] Indeed, no study has specifically examined TA and endoscopic sinus surgery in children.</offsets></p><p><offsets xml_i="16556" xml_f="16857" txt_i="10763" txt_f="11064">In this study, the efficacy of intra-venous TA in reducing bleeding during FESS in children was examined. There was a significant improvement in quality of the surgical field, significant decrease in volume of intra-operative bleeding, and duration of surgery in TA group as compared to placebo group.</offsets></p><p><offsets xml_i="16864" xml_f="17088" txt_i="11065" txt_f="11289">Previous studies have reported that intra-venous injection of tranexamic to patients undergoing cardiac surgery, oral surgery, liver transplantation, and prostate surgery reduced intra-operative and post-operative bleeding.[</offsets><xref ref-type="bibr" rid="ref14"><offsets xml_i="17122" xml_f="17124" txt_i="11289" txt_f="11291">14</offsets></xref><xref ref-type="bibr" rid="ref15"><offsets xml_i="17165" xml_f="17167" txt_i="11291" txt_f="11293">15</offsets></xref><xref ref-type="bibr" rid="ref16"><offsets xml_i="17208" xml_f="17210" txt_i="11293" txt_f="11295">16</offsets></xref><xref ref-type="bibr" rid="ref17"><offsets xml_i="17251" xml_f="17253" txt_i="11295" txt_f="11297">17</offsets></xref><xref ref-type="bibr" rid="ref18"><offsets xml_i="17294" xml_f="17296" txt_i="11297" txt_f="11299">18</offsets></xref><offsets xml_i="17303" xml_f="17304" txt_i="11299" txt_f="11300">]</offsets></p><p><offsets xml_i="17311" xml_f="17547" txt_i="11301" txt_f="11537">One recent retrospective study provides evidence for the effective usage of TA in the field of congenital cardiac surgery in reducing blood loss in the first 48 h post-operatively and reduction of the amount red blood cells transfused.[</offsets><xref ref-type="bibr" rid="ref19"><offsets xml_i="17581" xml_f="17583" txt_i="11537" txt_f="11539">19</offsets></xref><offsets xml_i="17590" xml_f="17591" txt_i="11539" txt_f="11540">]</offsets></p><p><offsets xml_i="17598" xml_f="17693" txt_i="11541" txt_f="11636">The dose of TA used in the present study was within the dose range previously found effective.[</offsets><xref ref-type="bibr" rid="ref20"><offsets xml_i="17727" xml_f="17729" txt_i="11636" txt_f="11638">20</offsets></xref><xref ref-type="bibr" rid="ref21"><offsets xml_i="17770" xml_f="17772" txt_i="11638" txt_f="11640">21</offsets></xref><xref ref-type="bibr" rid="ref22"><offsets xml_i="17813" xml_f="17815" txt_i="11640" txt_f="11642">22</offsets></xref><offsets xml_i="17822" xml_f="17951" txt_i="11642" txt_f="11771">] It has been proposed that therapeutic plasma concentration of tranexamic is 5-10 mg/l and is maintained for approximately 3 h.[</offsets><xref ref-type="bibr" rid="ref23"><offsets xml_i="17985" xml_f="17987" txt_i="11771" txt_f="11773">23</offsets></xref><offsets xml_i="17994" xml_f="18334" txt_i="11773" txt_f="12113">] Considering the relatively short duration of FESS, we assumed that a single intra-venous bolus dose of tranexamic 25 mg/Kg in children would fulfill the therapeutic goal. Albeit concerns for increased risk of post-operative complications. Similar study have utilized initial dose of 10 mg/kg followed by continuous intra-venous infusion.[</offsets><xref ref-type="bibr" rid="ref16"><offsets xml_i="18368" xml_f="18370" txt_i="12113" txt_f="12115">16</offsets></xref><offsets xml_i="18377" xml_f="18635" txt_i="12115" txt_f="12373">] There is a lack of dose-response in published data in the literature, where described initial bolus dosage range from 10 mg/kg to 100 mg/kg TA. In ours, continuous infusion of TA was not used after bolus dose; however, others had used continuous infusion.[</offsets><xref ref-type="bibr" rid="ref21"><offsets xml_i="18669" xml_f="18671" txt_i="12373" txt_f="12375">21</offsets></xref><xref ref-type="bibr" rid="ref24"><offsets xml_i="18712" xml_f="18714" txt_i="12375" txt_f="12377">24</offsets></xref><offsets xml_i="18721" xml_f="18722" txt_i="12377" txt_f="12378">]</offsets></p><p><offsets xml_i="18729" xml_f="18809" txt_i="12379" txt_f="12459">No, reported side-effects after TA administration during the pediatric surgery;[</offsets><xref ref-type="bibr" rid="ref20"><offsets xml_i="18843" xml_f="18845" txt_i="12459" txt_f="12461">20</offsets></xref><xref ref-type="bibr" rid="ref21"><offsets xml_i="18886" xml_f="18888" txt_i="12461" txt_f="12463">21</offsets></xref><xref ref-type="bibr" rid="ref25"><offsets xml_i="18929" xml_f="18931" txt_i="12463" txt_f="12465">25</offsets></xref><xref ref-type="bibr" rid="ref26"><offsets xml_i="18972" xml_f="18974" txt_i="12465" txt_f="12467">26</offsets></xref><xref ref-type="bibr" rid="ref27"><offsets xml_i="19015" xml_f="19017" txt_i="12467" txt_f="12469">27</offsets></xref><xref ref-type="bibr" rid="ref28"><offsets xml_i="19058" xml_f="19060" txt_i="12469" txt_f="12471">28</offsets></xref><offsets xml_i="19067" xml_f="19147" txt_i="12471" txt_f="12551">] likewise, we did not observe complications of TA therapy in the present study.</offsets></p><p><offsets xml_i="19154" xml_f="19520" txt_i="12552" txt_f="12918">The limitation of the present study is the exclusion of patients with the bleeding diathesis and abnormal prothrombin time, PTT or platelet counts from the study in which the use of the drug could be beneficial. Because, we aimed to study the effect of tranexamic alone on bleeding tendency and quality of the surgical field without any other factors affecting them.</offsets></p><p><offsets xml_i="19527" xml_f="19759" txt_i="12919" txt_f="13151">In conclusion, single intra-venous bolus dose of tranexamic in children during the FESS improves quality of surgical filed and intra-operative visibility. Furthermore, it reduces intra-operative bleeding and duration of the surgery.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stammberger</surname><given-names>H</given-names></name></person-group><article-title>Endoscopic endonasal surgery – Concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations</article-title><source>Otolaryngol Head Neck Surg</source><year>1986</year><volume>94</volume><fpage>143</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3083326</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>CW</given-names></name><name><surname>Gurucharri</surname><given-names>MJ</given-names></name><name><surname>Lazar</surname><given-names>RH</given-names></name><name><surname>Long</surname><given-names>TE</given-names></name></person-group><article-title>Functional endonasal sinus surgery (FESS) in the pediatric age group</article-title><source>Laryngoscope</source><year>1989</year><volume>99</volume><fpage>272</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2918799</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lusk</surname><given-names>RP</given-names></name><name><surname>Muntz</surname><given-names>HR</given-names></name></person-group><article-title>Endoscopic sinus surgery in children with chronic sinusitis: A pilot study</article-title><source>Laryngoscope</source><year>1990</year><volume>100</volume><fpage>654</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2348746</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazar</surname><given-names>RH</given-names></name><name><surname>Younis</surname><given-names>RT</given-names></name><name><surname>Gross</surname><given-names>CW</given-names></name></person-group><article-title>Pediatric functional endonasal sinus surgery: Review of 210 cases</article-title><source>Head Neck</source><year>1992</year><volume>14</volume><fpage>92</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1601655</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klabunde</surname><given-names>EH</given-names></name><name><surname>Falces</surname><given-names>E</given-names></name></person-group><article-title>Incidence of complications in cosmetic rhinoplasties</article-title><source>Plast Reconstr Surg</source><year>1964</year><volume>34</volume><fpage>192</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14198562</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldwyn</surname><given-names>RM</given-names></name></person-group><article-title>Unexpected bleeding after elective nasal surgery</article-title><source>Ann Plast Surg</source><year>1979</year><volume>2</volume><fpage>201</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">539747</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teichgraeber</surname><given-names>JF</given-names></name><name><surname>Riley</surname><given-names>WB</given-names></name><name><surname>Parks</surname><given-names>DH</given-names></name></person-group><article-title>Nasal surgery complications</article-title><source>Plast Reconstr Surg</source><year>1990</year><volume>85</volume><fpage>527</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">2315392</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoylaerts</surname><given-names>M</given-names></name><name><surname>Lijnen</surname><given-names>HR</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name></person-group><article-title>Studies on the mechanism of the antifibrinolytic action of tranexamic acid</article-title><source>Biochim Biophys Acta</source><year>1981</year><volume>673</volume><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">7193484</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horrow</surname><given-names>JC</given-names></name><name><surname>Van Riper</surname><given-names>DF</given-names></name><name><surname>Strong</surname><given-names>MD</given-names></name><name><surname>Grunewald</surname><given-names>KE</given-names></name><name><surname>Parmet</surname><given-names>JL</given-names></name></person-group><article-title>The dose-response relationship of tranexamic acid</article-title><source>Anesthesiology</source><year>1995</year><volume>82</volume><fpage>383</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7856897</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boezaart</surname><given-names>AP</given-names></name><name><surname>van der Merwe</surname><given-names>J</given-names></name><name><surname>Coetzee</surname><given-names>A</given-names></name></person-group><article-title>Comparison of sodium nitroprusside- and esmolol-induced controlled hypotension for functional endoscopic sinus surgery</article-title><source>Can J Anaesth</source><year>1995</year><volume>42</volume><fpage>373</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7614641</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieskiewicz</surname><given-names>A</given-names></name><name><surname>Olszewska</surname><given-names>E</given-names></name><name><surname>Rogowski</surname><given-names>M</given-names></name><name><surname>Grycz</surname><given-names>E</given-names></name></person-group><article-title>Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: A preliminary investigation</article-title><source>Ann Otol Rhinol Laryngol</source><year>2006</year><volume>115</volume><fpage>490</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16900802</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>G</given-names></name><name><surname>Low</surname><given-names>JM</given-names></name><name><surname>Tan</surname><given-names>PE</given-names></name><name><surname>van Hasselt</surname><given-names>CA</given-names></name></person-group><article-title>Plasma catecholamine levels during functional endoscopic sinus surgery</article-title><source>Clin Otolaryngol Allied Sci</source><year>1995</year><volume>20</volume><fpage>213</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7554329</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>AR</given-names></name></person-group><article-title>Anaesthesia with profound hypotension for middle ear surgery</article-title><source>Br J Anaesth</source><year>1977</year><volume>49</volume><fpage>447</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">861111</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanasiadis</surname><given-names>T</given-names></name><name><surname>Beule</surname><given-names>AG</given-names></name><name><surname>Wormald</surname><given-names>PJ</given-names></name></person-group><article-title>Effects of topical antifibrinolytics in endoscopic sinus surgery: A pilot randomized controlled trial</article-title><source>Am J Rhinol</source><year>2007</year><volume>21</volume><fpage>737</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">18201457</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaniv</surname><given-names>E</given-names></name><name><surname>Shvero</surname><given-names>J</given-names></name><name><surname>Hadar</surname><given-names>T</given-names></name></person-group><article-title>Hemostatic effect of tranexamic acid in elective nasal surgery</article-title><source>Am J Rhinol</source><year>2006</year><volume>20</volume><fpage>227</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16686395</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alimian</surname><given-names>M</given-names></name><name><surname>Mohseni</surname><given-names>M</given-names></name></person-group><article-title>The effect of intravenous tranexamic acid on blood loss and surgical field quality during endoscopic sinus surgery: A placebo-controlled clinical trial</article-title><source>J Clin Anesth</source><year>2011</year><volume>23</volume><fpage>611</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22137511</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>CJ</given-names></name><name><surname>Goa</surname><given-names>KL</given-names></name></person-group><article-title>Tranexamic acid: A review of its use in surgery and other indications</article-title><source>Drugs</source><year>1999</year><volume>57</volume><fpage>1005</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">10400410</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>RA</given-names></name></person-group><article-title>Advances in surgical care of infants and children with congenital heart disease</article-title><source>Curr Opin Pediatr</source><year>1995</year><volume>7</volume><fpage>572</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8541959</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>R</given-names></name><name><surname>Palma</surname><given-names>G</given-names></name><name><surname>Poli</surname><given-names>V</given-names></name><name><surname>Palumbo</surname><given-names>S</given-names></name><name><surname>Russolillo</surname><given-names>V</given-names></name><name><surname>Cioffi</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Tranexamic acid therapy in pediatric cardiac surgery: A single-center study</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><fpage>1302</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22819471</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>RW</given-names></name><name><surname>Zimmerman</surname><given-names>AA</given-names></name><name><surname>Laussen</surname><given-names>PC</given-names></name><name><surname>Mayer</surname><given-names>JE</given-names></name><name><surname>Gorlin</surname><given-names>JB</given-names></name><name><surname>Burrows</surname><given-names>FA</given-names></name></person-group><article-title>The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery</article-title><source>Anesth Analg</source><year>1997</year><volume>84</volume><fpage>990</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9141920</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethna</surname><given-names>NF</given-names></name><name><surname>Zurakowski</surname><given-names>D</given-names></name><name><surname>Brustowicz</surname><given-names>RM</given-names></name><name><surname>Bacsik</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>LJ</given-names></name><name><surname>Shapiro</surname><given-names>F</given-names></name></person-group><article-title>Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery</article-title><source>Anesthesiology</source><year>2005</year><volume>102</volume><fpage>727</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15791100</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durán de la Fuente</surname><given-names>P</given-names></name><name><surname>García-Fernández</surname><given-names>J</given-names></name><name><surname>Pérez-López</surname><given-names>C</given-names></name><name><surname>Carceller</surname><given-names>F</given-names></name><name><surname>Gilsanz</surname><given-names>Rodríguez F</given-names></name></person-group><article-title>Usefulness of tranexamic acid in cranial remodeling surgery</article-title><source>Rev Esp Anestesiol Reanim</source><year>2003</year><volume>50</volume><fpage>388</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">14601366</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>MC</given-names></name><name><surname>Calder</surname><given-names>P</given-names></name><name><surname>Rosenfeld</surname><given-names>P</given-names></name><name><surname>Scott</surname><given-names>G</given-names></name></person-group><article-title>The use of tranexamic acid to reduce blood loss during total hip arthroplasty: An observational study</article-title><source>Ann R Coll Surg Engl</source><year>2005</year><volume>87</volume><fpage>99</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">15826417</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadure</surname><given-names>C</given-names></name><name><surname>Sauter</surname><given-names>M</given-names></name><name><surname>Bringuier</surname><given-names>S</given-names></name><name><surname>Bigorre</surname><given-names>M</given-names></name><name><surname>Raux</surname><given-names>O</given-names></name><name><surname>Rochette</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study</article-title><source>Anesthesiology</source><year>2011</year><volume>114</volume><fpage>856</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">21358317</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulutcu</surname><given-names>FS</given-names></name><name><surname>Ozbek</surname><given-names>U</given-names></name><name><surname>Polat</surname><given-names>B</given-names></name><name><surname>Yalçin</surname><given-names>Y</given-names></name><name><surname>Karaci</surname><given-names>AR</given-names></name><name><surname>Bayindir</surname><given-names>O</given-names></name></person-group><article-title>Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination?</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><fpage>41</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15649162</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Bisoi</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Mittal</surname><given-names>D</given-names></name><name><surname>Kale</surname><given-names>S</given-names></name><name><surname>Kiran</surname><given-names>U</given-names></name><etal></etal></person-group><article-title>Dose comparison of tranexamic acid in pediatric cardiac surgery</article-title><source>Asian Cardiovasc Thorac Ann</source><year>2004</year><volume>12</volume><fpage>121</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15213077</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neilipovitz</surname><given-names>DT</given-names></name><name><surname>Murto</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>L</given-names></name><name><surname>Barrowman</surname><given-names>NJ</given-names></name><name><surname>Splinter</surname><given-names>WM</given-names></name></person-group><article-title>A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>82</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11429344</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>JA</given-names></name><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Luntley</surname><given-names>J</given-names></name><name><surname>Harder</surname><given-names>J</given-names></name><name><surname>Aleissa</surname><given-names>S</given-names></name><name><surname>Parsons</surname><given-names>D</given-names></name></person-group><article-title>Perioperative blood transfusion requirements in pediatric scoliosis surgery: The efficacy of tranexamic acid</article-title><source>J Pediatr Orthop</source><year>2009</year><volume>29</volume><fpage>300</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19305284</pub-id></element-citation></ref></ref-list></back></article>